**14. Conclusions**

DNA methylation changes at differentially methylated sites or regions have been linked to metabolic diseases such as obesity and T2D. Thus, changes in the epigenome may provide an underlying molecular mechanism for the deleterious metabolic health outcomes associated with these conditions. Conversely, coordinated reversal of these changes may improve metabolic health after therapeutic intervention, and this provides optimism for the future.
